FDA delays decision on Moderna RSV vaccine
Moderna on Friday said the Food and Drug Administration has postponed an approval decision on its experimental vaccine for respiratory syncytial virus due to “administrative constraints,” extending a review the regulator had expected to complete by Sunday. …